Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sitafloxacin and Garenoxacin May Overcome the Antibiotic Resistance of <i>Helicobacter pylori</i> with <i>gyrA</i> Mutation

3 Feb 2009

Abstract excerpt

Resistance of Helicobacter pylori to the standard therapeutic antimicrobials (clarithromycin, metronidazole, amoxicillin [AMX], and tetracycline) ([9][1]) has been demonstrated; therefore, there is an urgent need to introduce other treatment options. Fluoroquinolones, such as levofloxacin (LVX) and

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gastric Cancer Management and Outcomes
Share to Helicobacter pylori-related gastroenterology studies
Share to Veterinary medicine and infectious diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19188389
DOI: 10.1128/aac.00049-09

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sitafloxacin and Garenoxacin May Overcome the Antibiotic Resistance of <i>Helicobacter pylori</i> with <i>gyrA</i> MutationPMID 19188389Read ↗

Antimicrobial Resistance and Genetic Characteristics that Might be Related to Antibiotic Resistance of 112 Helicobacter Pylori Shanghai IsolatesSemantic proximity Read ↗

Antimicrobial resistance patterns and genetic elements associated with the antibiotic resistance of Helicobacter pylori strains from ShanghaiSemantic proximity Read ↗

Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan.Semantic proximity Read ↗

Update on quinolone-containing rescue therapies for Helicobacter pylori infection.Semantic proximity Read ↗

Antibiotic resistance and associated gene mutations of Helicobacter pylori in children: a three-year retrospective study in Shanghai, China.Semantic proximity Read ↗

Exploration of the molecular mechanisms underlying the antibiotic resistance of Helicobacter pylori: A whole-genome sequencing-based study in Southern China.Semantic proximity Read ↗

Acquisition of double mutation in gyrA caused high resistance to sitafloxacin in Helicobacter pylori after unsuccessful eradication with sitafloxacin-containing regimensSemantic proximity Read ↗

Antibiotic resistance of Helicobacter pylori in Nanjing, China: A cross-section study from 2018 to 2023Semantic proximity Read ↗

Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan.Semantic proximity Read ↗

Molecular detection of H. pylori antibiotic-resistant genes and molecular docking analysis.Semantic proximity Read ↗

Resistance mechanisms ofHelicobacter pyloriand its dual target precise therapySemantic proximity Read ↗

Efficacy of genotypic susceptibility-guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.